South Korea warns against methylphenidate misuse as 'study drug

South Korean authorities are launching a public awareness campaign to prevent the misuse of methylphenidate, an ADHD medication often misidentified by students and parents as a ‘study drug’ to enhance concentration.

The Ministry of Food and Drug Safety, in collaboration with the Ministry of Education and the Ministry of Gender Equality and Family, has released promotional videos to clarify that the substance is a medical narcotic intended for treating Attention Deficit Hyperactivity Disorder (ADHD), not for academic performance enhancement.

Experts warn that individuals without ADHD who consume the drug may experience severe side effects, including headaches, anxiety, and in extreme cases, hallucinations. Authorities have already detected over 1,700 illegal online advertisements and distribution posts related to methylphenidate through August of this year.

To combat illegal distribution via social media, the government is conducting special inspections, particularly ahead of the College Scholastic Ability Test (CSAT). Officials emphasized that purchasing or sharing the medication without a prescription is a punishable offense under current laws.